← Open Payments lookup

KELLY VANWYCK: Open Payments

NPI 1104334655 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$436 in 24 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $382 · 2025 $436

Food & beverage: $436
CompanyPaymentsAmount
Novo Nordisk Inc8$140
Otsuka America Pharmaceutical, Inc.3$55
PFIZER INC.3$52
Exact Sciences Corporation2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
AstraZeneca Pharmaceuticals LP2$30
Astellas Pharma US Inc1$22
Axsome Therapeutics, Inc.1$20
Lilly USA, LLC1$17
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: REXULTI, Cologuard Collection Kit, CAPLYTA, PREVNAR 20, Wegovy, Ozempic, Veozah, Auvelity.

Industry payments across NJ — which companies pay providers there.